A weak neutralizing antibody response to hepatitis C virus envelope glycoprotein enhances virus infection.

by Keith Meyer, Arup Banerjee, Sharon E Frey, Robert B Belshe, Ranjit Ray
Published 2011-01-01

Molecular analyses and phylogeny of the herpes simplex virus 2 US9 and glycoproteins gE/gI obtained from infected subjects during the Herpevac Trial for Women.

by Kelsey L Rowe, Miguel A Minaya, Robert B Belshe, Lynda A Morrison
Published 2019-01-01

The herpevac trial for women: Sequence analysis of glycoproteins from viruses obtained from infected subjects.

by Miguel A Minaya, Maria Korom, Hong Wang, Robert B Belshe, Lynda A Morrison
Published 2017-01-01

Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays.

by Tamara P Blevins, Yinyi Yu, Robert B Belshe, Abbie R Bellamy, Lynda A Morrison
Published 2019-01-01

Higher Throughput Quantification of Neutralizing Antibody to Herpes Simplex Viruses.

by Tamara P Blevins, Michelle C Mitchell, Maria Korom, Hong Wang, Yinyi Yu, Lynda A Morrison, Robert B Belshe
Published 2015-01-01

New Concepts for Vaccines

by Trudy V. Murphy, Gary Dubin, Robert B. Belshe, Thomas P. Monath, Irene B. Glowinski, Susan A. Daniels, Joel C. Gaydos
Published 2004-11-01

Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.

by Gallen B Triana-Baltzer, Larisa V Gubareva, Alexander I Klimov, David F Wurtman, Ronald B Moss, Maria Hedlund, Jeffrey L Larson, Robert B Belshe, Fang Fang
Published 2009-11-01

A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans.

by John Lok Man Law, Chao Chen, Jason Wong, Darren Hockman, Deanna M Santer, Sharon E Frey, Robert B Belshe, Takaji Wakita, Jens Bukh, Christopher T Jones, Charles M Rice, Sergio Abrignani, D Lorne Tyrrell, Michael Houghton
Published 2013-01-01